Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are ten patents…
The post New patent expiration for Boehringer Ingelheim drug TRADJE…
New patent expiration for Boehringer Ingelheim drug TRADJENTA Read Post »
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent expiration for Boehringer Ingelheim drug J…
New patent expiration for Boehringer Ingelheim drug JENTADUETO Read Post »
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent expiration for Boehringer Ingelheim drug GLYX…
New patent expiration for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent expiration for Boehringer Ingelheim drug TRIJARD…
New patent expiration for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Boehringer Ingelheim drug JENTADU…
New patent expiration for Boehringer Ingelheim drug JENTADUETO XR Read Post »
Annual Drug Patent Expirations for BINOSTO Binosto is a drug marketed by Ascend Theraps Us and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Ascend Theraps drug BINOSTO appeared first on …
New patent expiration for Ascend Theraps drug BINOSTO Read Post »
Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in one NDA. There are six patents protecting this drug. SUMAVEL…
The post New patent expiration for Endo Ventures drug SUMAVEL DO…
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
SIGNIFOR LAR KIT (pasireotide pamoate) Recordati rare Patent: 8,822,637 Expiration: Aug 6, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for …
Drug Patent Expirations for the Week of August 6, 2023 Read Post »
Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…
The post New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA…
New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA KIT Read Post »
Annual Drug Patent Expirations for SIGNIFOR+LAR+KIT Signifor Lar Kit is a drug marketed by Recordati Rare and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT …
New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT Read Post »